Continuous Assessment of Cerebral Autoregulation in TBI Patients Using ICM+
In this month's webinar, Dr. Peter Smielewski of Cambridge Neuroscience presents the current state of the art in continuous assessment of cerebral autoregulation in patients undergoing neuro-monitoring. In particular, he illustrates a practical approach to the autoregulation-oriented management of TBI patients and discusses the clinical impact of such therapy and the road ahead.
In the industry partner section, Dr. Smielewski focuses on aspects of integration of ICM+ with the Moberg CNS Monitor and discusses the benefits of such synergy.
- Calculating optimal CPP values
- Effect of PRx on patient outcome
- Integrating ICM+ with the CNS Monitor
Friday, June 8, 2018
The views and opinions expressed by the presenter and other third parties do not necessarily reflect those of Moberg Research, Inc. Moberg Research, Inc. makes no clinical claims regarding information described by the presenter and other third parties.